As the pharmaceutical glass packaging market growth forecasts predict, it can be speculated that the market will traverse its progress path at a CAGR of 9.5%. The likelihood of the market size inflates is high, forecasting its valuation to reach US$ 54.6 billion by 2034 from US$ 22 billion measured in 2024.
| Attributes | Key Insights |
|---|---|
| Estimated Market Size in 2024 | US$ 22 billion |
| Projected Market Value in 2034 | US$ 54.6 billion |
| Value-based CAGR from 2024 to 2034 | 9.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The pharmaceutical glass packaging market growth was accelerated during the forecasted period at an impressive 12% CAGR. It ensured its size will float around US$ 19.8 billion in 2023. The pharmaceutical glass packaging market size was measured at US$ 12.5 billion in 2019.
Due to the exponential number of patients during the pandemic, the requirement for medicines and relevant medical equipment increased. This drove the pharmaceutical glass packaging market growth during the historical period.
| Historical CAGR from 2019 to 2023 | 12% |
|---|---|
| Forecast CAGR from 2024 to 2034 | 9.5% |
The growing pharmaceutical industry will mainly generate the demand. The aging population, the rising prevalence of chronic diseases, and rising accidental cases create more demand for medicines. Hence, the demand for medicinal packaging rises.
Glass packaging materials fulfill efficient storage and handling requirements of patient samples. Due to this, its demand will increase. Hence, this factor will enlarge the pharmaceutical glass packaging market size.
Principal Consultant
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Future Market Insights analyzes the following three markets: the pharmaceutical glass packaging market, the pharmaceutical packaging market, governed by technological developments, and the pharmaceutical packaging equipment market, influenced by the growing focus on patient safety.
Pharmaceutical Glass Packaging Market:
| Attributes | Pharmaceutical Glass Packaging Market |
|---|---|
| CAGR from 2024 to 2034 | 9.5% |
| Key Trends | The demand for biopharmaceuticals is rising, which enhances the need for advanced glass packaging. It supports the pharmaceutical glass packaging market growth forecasts. |
| Growth Factor | The growing pharmaceutical industry helps the pharmaceutical glass packaging market size to grow due to frequent medicinal demands. |
Pharmaceutical Packaging Market:
| Attributes | Pharmaceutical Packaging Market |
|---|---|
| CAGR from 2024 to 2034 | 7.1% |
| Key Trends | The growing demand for smart packaging solutions and anti-counterfeiting measures is trending. |
| Growth Factor | Technological infrastructure will likely drive packaging innovation, driving the market. |
Pharmaceutical Packaging Equipment Market:
| Attributes | Pharmaceutical Packaging Equipment Market |
|---|---|
| CAGR from 2023 to 2033 | 4.1% |
| Key Trends | To enhance functioning within the industry, pharmaceutical companies outsource packaging services. |
| Growth Factor | The increasing emphasis on patient safety will likely drive equipment manufacturing, fueling the market advancement. |
The increasing pharmaceutical glass packaging market size in the Asia-Pacific region is attributed to the government’s support of constantly evolving medical infrastructure.
Leading players in the pharmaceutical glass packaging market are encouraged to produce freely due to rising domestic production demand in the region.
The vastness of North America’s pharmaceutical glass packaging market size will be attributed to technological developments in the pharmaceutical industry.
Europe is another key contributor to the market. It paints an assertive picture of the global pharmaceutical glass packaging market growth forecasts.
Forecast CAGRs from 2024 to 2034
| Countries | Forecasted CAGR |
|---|---|
| The United States of America | 9.8% |
| China | 10.3% |
| The United Kingdom | 10.7% |
| Japan | 11.1% |
| South Korea | 12.1% |
The United States of America will lead North America, and pharmaceutical glass packaging market growth forecasts suggest that it will be accelerated at a 9.8% CAGR. Also, the pharmaceutical glass packaging market size will reach US$ 9.7 billion during the forecasted period.
The growing prevalence of accidental cases and chronic diseases surges the demand for vaccines, tissue transplants, etc. Hence, this drives the demand for biologics, requiring appropriate packing to avoid medicine leakage.
The pharmaceutical glass packaging market in China expectes its advancement to be pegged at a CAGR of 10.3% through 2034. The Chinese people prefer premium products as their disposable income rises.
Due to this, the subject market will likely be augmented by leading players in the pharmaceutical glass packaging market by innovating packaging solutions. Hence, this will fuel its growth, and the pharmaceutical glass packaging market size will likely be lifted to US$ 8.6 billion by 2034.
The United Kingdom’s pharmaceutical glass packaging market growth forecasts predict its market size will elevate to US$ 2.2 billion by 2034. Consumer inclination toward personalized medicines creates demand for premium packaging.
Also, the rising demand for child-resistant packaging encourages leading players in the pharmaceutical glass packaging market to provide premium packaging solutions, driving the market. Therefore, these factors will accelerate the UK’s pharmaceutical glass packaging market growth forecasts at a 10.7% rate.
Japan’s senior population is rising, which generally drives the demand for medicines. As a result, the demand for pharmaceutical packaging also rises. Moreover, the demand for generic and geriatric-friendly medicines is rising, driving the market segment.
Thus, Japan’s pharmaceutical glass packaging market size will likely reach US$ 6.1 billion by 2034. Moreover, the pharmaceutical glass packaging market growth forecasts project an impressive CAGR of 11.1%.
The South Korean pharmaceutical glass packaging market growth forecasts the highest CAGR of 12.1%. Also, the pharmaceutical glass packaging market size will likely reach US$ 3.6 billion by 2034.
The country’s biopharmaceutical sector is exponentially growing. Also, the country’s budget surplus encourages its exports further. The government also encourages leading players in the pharmaceutical glass packaging market to export their medicines. As a result, high-quality packaging for medicines is favored, driving the market.
Generic medicines are an excellent replacement for branded medicines due to their equivalent medicinal value and relatively lower prices. This segment is contributing the highest to the market.
Due to less reactivity of vials, patients' samples can be stored safely. Due to this, the demand for this market segment is increasing.
| Category | Top Drug Type - Generic |
|---|---|
| Market Share in 2023 | 64% |
| CAGR % 2024 to End of Forecast(2034) | 9.3% |
| Market Segment Drivers |
|
| Category | Top Product - Vials |
|---|---|
| Market Share in 2023 | 32.5% |
| CAGR % 2024 to End of Forecast(2034) | 9.1% |
| Market Segment Drivers |
|
The pharmaceutical glass packaging market's competitive landscape is vast, and many leading players actively participate. Due to this, the attractiveness of the marketplace is increasing.
However, the lucrative growth chances for the new entrants are bleak due to their large market occupancy. They can penetrate the market using innovation as a prime strategy.
Leading players in the pharmaceutical glass packaging market expand using key strategies, giving them a better market share. Key strategic initiatives include mergers and acquisitions, product innovation, collaborations, and partnerships.
Key Market Developments
| Attributes | Details |
|---|---|
| Estimated Market Size in 2024 | US$ 22 billion |
| Projected Market Valuation in 2034 | US$ 54.6 billion |
| Value-based CAGR 2024 to 2034 | 9.5% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in US$ billion |
| Key Regions Covered |
|
| Key Market Segments Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
The pharmaceutical glass packaging market is estimated to progress at a CAGR of 9.5% through 2034.
The pharmaceutical glass packaging market will likely reach US$ 54.6 billion by 2034.
The pharmaceutical glass packaging market will attain a market size of US$ 22 billion in 2024.
The Pharmaceutical glass packaging market's vials segment held 32.5% of the market share in 2023.
The pharmaceutical glass packaging market's generic segment held 64% of the market share in 2023.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Manufacturer 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Material 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material, 2024 to 2034 5.3.1. Type I 5.3.2. Type II 5.3.3. Type III 5.4. Y-o-Y Growth Trend Analysis By Material, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Material, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034 6.3.1. Vials 6.3.1.1. Small Vials 6.3.1.2. Large Vials 6.3.2. Bottles 6.3.2.1. Small Bottles 6.3.2.2. Large Bottles 6.3.3. Cartridges & Syringes 6.3.4. Ampoules 6.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Drug Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Drug Type, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Drug Type, 2024 to 2034 7.3.1. Generic 7.3.2. Branded 7.3.3. Biologic 7.4. Y-o-Y Growth Trend Analysis By Drug Type, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Drug Type, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Material 9.2.3. By Product 9.2.4. By Drug Type 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Material 9.3.3. By Product 9.3.4. By Drug Type 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Material 10.2.3. By Product 10.2.4. By Drug Type 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Material 10.3.3. By Product 10.3.4. By Drug Type 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Material 11.2.3. By Product 11.2.4. By Drug Type 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Material 11.3.3. By Product 11.3.4. By Drug Type 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Material 12.2.3. By Product 12.2.4. By Drug Type 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Material 12.3.3. By Product 12.3.4. By Drug Type 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Material 13.2.3. By Product 13.2.4. By Drug Type 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Material 13.3.3. By Product 13.3.4. By Drug Type 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Material 14.2.3. By Product 14.2.4. By Drug Type 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Material 14.3.3. By Product 14.3.4. By Drug Type 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Material 15.2.3. By Product 15.2.4. By Drug Type 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Material 15.3.3. By Product 15.3.4. By Drug Type 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Material 16.1.2.2. By Product 16.1.2.3. By Drug Type 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Material 16.2.2.2. By Product 16.2.2.3. By Drug Type 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Material 16.3.2.2. By Product 16.3.2.3. By Drug Type 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Material 16.4.2.2. By Product 16.4.2.3. By Drug Type 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Material 16.5.2.2. By Product 16.5.2.3. By Drug Type 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Material 16.6.2.2. By Product 16.6.2.3. By Drug Type 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Material 16.7.2.2. By Product 16.7.2.3. By Drug Type 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Material 16.8.2.2. By Product 16.8.2.3. By Drug Type 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Material 16.9.2.2. By Product 16.9.2.3. By Drug Type 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Material 16.10.2.2. By Product 16.10.2.3. By Drug Type 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Material 16.11.2.2. By Product 16.11.2.3. By Drug Type 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Material 16.12.2.2. By Product 16.12.2.3. By Drug Type 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Material 16.13.2.2. By Product 16.13.2.3. By Drug Type 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Material 16.14.2.2. By Product 16.14.2.3. By Drug Type 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Material 16.15.2.2. By Product 16.15.2.3. By Drug Type 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Material 16.16.2.2. By Product 16.16.2.3. By Drug Type 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Material 16.17.2.2. By Product 16.17.2.3. By Drug Type 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Material 16.18.2.2. By Product 16.18.2.3. By Drug Type 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Material 16.19.2.2. By Product 16.19.2.3. By Drug Type 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Material 16.20.2.2. By Product 16.20.2.3. By Drug Type 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Material 16.21.2.2. By Product 16.21.2.3. By Drug Type 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Material 16.22.2.2. By Product 16.22.2.3. By Drug Type 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Material 16.23.2.2. By Product 16.23.2.3. By Drug Type 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Material 17.3.3. By Product 17.3.4. By Drug Type 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Corning Incorporated 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Nipro Corporation 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. SGD S.A. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Stoelzle Oberglas GmbH 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Bormioli Pharma S.p.A. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. West Pharmaceutical Services, Inc. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Schott AG 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Gerresheimer AG 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Shandong Medicinal Glass Co., Ltd. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Beatson Clark 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. Ardagh Group S.A 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Packaging
February 2022
REP-GB-1446
February 2024
200 pages
Explore Packaging Insights
View Reports
Pharmaceutical Glass Packaging Market
